GB1433507A - Pharmaceutically active 2-substituted adenosine-3,5-cyclic monophosphates - Google Patents

Pharmaceutically active 2-substituted adenosine-3,5-cyclic monophosphates

Info

Publication number
GB1433507A
GB1433507A GB2303573A GB2303573A GB1433507A GB 1433507 A GB1433507 A GB 1433507A GB 2303573 A GB2303573 A GB 2303573A GB 2303573 A GB2303573 A GB 2303573A GB 1433507 A GB1433507 A GB 1433507A
Authority
GB
United Kingdom
Prior art keywords
alkyl
salt
cycloalkyl
alkenyl
prepared
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB2303573A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda Pharmaceutical Co Ltd
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of GB1433507A publication Critical patent/GB1433507A/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16Purine radicals
    • C07H19/20Purine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GB2303573A 1972-05-15 1973-05-15 Pharmaceutically active 2-substituted adenosine-3,5-cyclic monophosphates Expired GB1433507A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP47048372A JPS4911896A (en, 2012) 1972-05-15 1972-05-15

Publications (1)

Publication Number Publication Date
GB1433507A true GB1433507A (en) 1976-04-28

Family

ID=12801489

Family Applications (1)

Application Number Title Priority Date Filing Date
GB2303573A Expired GB1433507A (en) 1972-05-15 1973-05-15 Pharmaceutically active 2-substituted adenosine-3,5-cyclic monophosphates

Country Status (9)

Country Link
JP (1) JPS4911896A (en, 2012)
AT (1) AT331998B (en, 2012)
AU (1) AU5567573A (en, 2012)
CA (1) CA1000696A (en, 2012)
DE (1) DE2324130A1 (en, 2012)
FR (1) FR2184813B1 (en, 2012)
GB (1) GB1433507A (en, 2012)
HU (1) HU169628B (en, 2012)
NL (1) NL7306790A (en, 2012)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0929218A4 (en) * 1996-10-30 2001-05-16 Univ North Carolina P2Y RECEPTOR ANTAGONISTS

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR205247A1 (es) * 1973-02-07 1976-04-21 Icn Pharmaceuticals Procedimiento para preparar derivados de amp 2-substituidos
JPS54103891A (en) * 1978-01-28 1979-08-15 Kikkoman Corp Novel 2-fluoro-adenosine-3',5'-cyclic phosphoric acid and its preparation
WO1990011080A1 (fr) * 1989-03-24 1990-10-04 Daiichi Pharmaceutical Co., Ltd. Medicament ameliorant les fonctions cerebrales
TR200200617T2 (tr) * 1999-06-22 2002-06-21 Cv Therapeutics, Inc. Tiofen A2a reseptör agonistleri.
US7342003B2 (en) 2001-10-25 2008-03-11 King Pharmaceuticals Research And Development, Inc. Synthesis of 2-aralkyloxyadenosines, 2-alkoxyadenosines, and their analogs
BR0213557A (pt) 2001-10-25 2004-10-26 King Pharmaceuticals Res & Dev Método para a sìntese de uma 2-aralquiloxiadenosina ou uma 2-alcoxiadenosina e processo para a preparação de um composto

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1336441A (en) * 1969-10-10 1973-11-07 Anvar Derivatives of cyclo adenosine-3,5-phosphoric acid and their preparation
FR2068728A1 (en) * 1969-10-10 1971-09-03 Anvar Cyclic (iso)adenosine-3' 5'-monophosphoric - acid derivs

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0929218A4 (en) * 1996-10-30 2001-05-16 Univ North Carolina P2Y RECEPTOR ANTAGONISTS

Also Published As

Publication number Publication date
AU5567573A (en) 1974-11-14
ATA424373A (de) 1975-12-15
FR2184813B1 (en, 2012) 1976-07-02
JPS4911896A (en, 2012) 1974-02-01
HU169628B (en, 2012) 1976-12-28
FR2184813A1 (en, 2012) 1973-12-28
AT331998B (de) 1976-09-10
CA1000696A (en) 1976-11-30
NL7306790A (en, 2012) 1973-11-19
DE2324130A1 (de) 1973-11-29

Similar Documents

Publication Publication Date Title
ES474288A1 (es) Un procedimiento para la preparacion de derivados del acido 7-oxo-1-aza-biciclo-(3,2,0)-hept-2-en-carboxilico 3 y 6-sus-tituidos
HUT45543A (en) Process for producing rebeccamycin analogues and pharmaceutical compositions containing them as active component
ES514240A0 (es) Un procedimiento para la prepracion de nuevos derivados de acidos 2-carbamimidoil-1-,carbadestiapen-2-en-3-carboxilados.
GB1366379A (en) Herbicidal phosphonomethylglycine compounds and compositions containing them
ES467565A1 (es) Procedimiento para la preparacion de nuevas 4-acilamino-fe- nil-etanol-aminas.
ES474215A1 (es) Procedimiento para la preparacion de derivados imidazolile- tiloxialcoxilicos y sus analogos con agrupacion tio
GB1351501A (en) Adenosine derivatives and the production thereof
GB1433507A (en) Pharmaceutically active 2-substituted adenosine-3,5-cyclic monophosphates
GB1335493A (en) 1a-beta-d arabinofuranosyl cytosine derivatives and process for making same
ES482787A1 (es) Un procedimiento para preparar derivados de flavano, mono- di-y tri-sustituidos.
GB1531963A (en) Pyrido(1,2alpha)pyrimidine derivatives
GB1432809A (en) Coumarin derivatives
EP0219852A3 (en) Chartreusin derivatives, salts thereof, antitumorous compositions containing the same, and processes for producing the same
GB1355204A (en) Antidote compositions and method of use with herbicides
GB1309622A (en) Phorsphoric acid esters and their use as insecticides acaricides and nematocides
GB1144875A (en) Improvements in and relating to pharmacologically-active guanidine derivatives
GB1421446A (en) Disalkylamino esters of benzopyranopyridines and compositions containing the same
ES8207538A1 (es) Un procedimiento para la preparacion de acidos 1-carbadetiapen-2-em-3-carboxilicos 6-, 1- y 2-sustituidos.
GB1198459A (en) Substituted 2-Amino and 2-Nitrobenzamides and preparation thereof
ES453162A1 (es) Un procedimiento para la obtencion de compuestos heteroci- clicos.
GR1000740B (el) Νεα παραγωγα αμινοπροπανολης, η παρασκευη αυτων και φαρμακευτικες συνθεσεις οι οποιες περιεχουν αυτα.
EP0016411A3 (en) 5(10- 9)abeo-ergoline derivatives, their preparation, and therapeutic compositions containing them
GB1197691A (en) Substituted Thienoimidazoles
GB1464431A (en) Indolobenzazepine derivatives and a process for the manufacture thereof
ES442009A1 (es) Metodo para la preparacion de una composicion para combatir hongos fitopatogenos.

Legal Events

Date Code Title Description
PS Patent sealed
PLNP Patent lapsed through nonpayment of renewal fees